标题
KRASmutation in lung metastases from colorectal cancer: prognostic implications
作者
关键词
-
出版物
Cancer Medicine
Volume 5, Issue 2, Pages 256-264
出版商
Wiley
发表日期
2015-12-30
DOI
10.1002/cam4.592
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer
- (2015) Hisashi Suzuki et al. ANNALS OF THORACIC SURGERY
- KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer
- (2015) S Renaud et al. BRITISH JOURNAL OF CANCER
- FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study
- (2015) Nicola Personeni et al. Clinical Colorectal Cancer
- Risk factors for survival after lung metastasectomy in colorectal cancer patients: systematic review and meta-analysis
- (2015) Michel Gonzalez et al. Future Oncology
- Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancer
- (2014) V. K. Morris et al. ANNALS OF ONCOLOGY
- Association between KRAS mutation and lung metastasis in advanced colorectal cancer
- (2014) A A L Pereira et al. BRITISH JOURNAL OF CANCER
- KRASmutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases
- (2014) Nancy E. Kemeny et al. CANCER
- RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer
- (2014) Rona Yaeger et al. CANCER
- Pulmonary metastasectomy for colorectal cancer: How many nodules, how many times?
- (2014) Hong Kwan Kim WORLD JOURNAL OF GASTROENTEROLOGY
- RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
- (2013) Jean-Nicolas Vauthey et al. ANNALS OF SURGERY
- EGFR, BRAF and KRAS Status in Patients Undergoing Pulmonary Metastasectomy from Primary Colorectal Carcinoma: A Prospective Follow-Up Study
- (2013) Thomas Schweiger et al. ANNALS OF SURGICAL ONCOLOGY
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival
- (2013) Chloe E. Atreya et al. Cancer Medicine
- Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
- (2012) Mi-Jung Kim et al. BMC CANCER
- Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases
- (2012) Elena Miranda et al. CANCER
- Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: Beyond KRAS mutations
- (2012) Ana Custodio et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Poor prognosis ofKRASorBRAFmutant colorectal liver metastasis without microsatellite instability
- (2012) Yuzo Umeda et al. Journal of Hepato-Biliary-Pancreatic Sciences
- The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer
- (2012) Francesco Sclafani et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma
- (2012) Luigi Laghi et al. PLoS One
- KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer
- (2011) J. Tie et al. CLINICAL CANCER RESEARCH
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Current treatment for colorectal liver metastases
- (2011) Evangelos P Misiakos WORLD JOURNAL OF GASTROENTEROLOGY
- PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis
- (2011) Arantza Fariña Sarasqueta et al. CELLULAR ONCOLOGY
- Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
- (2010) L J M Mekenkamp et al. BRITISH JOURNAL OF CANCER
- Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study
- (2010) E. Mitry et al. GUT
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
- (2009) A. Sartore-Bianchi et al. CANCER RESEARCH
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis
- (2009) Paloma Cejas et al. PLoS One
- Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study
- (2008) Evangelia Razis et al. BMC CANCER
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search